Stereotactic Body Radiation Therapy in Recurrent Hepatocellular Carcinoma
- 30 September 2012
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 84 (2), 355-361
- https://doi.org/10.1016/j.ijrobp.2011.11.058
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Stereotactic Radiotherapy of Hepatocellular Carcinoma: Preliminary ResultsTechnology in Cancer Research & Treatment, 2010
- Radiotherapy for hepatocellular carcinoma: Systematic review of radiobiology and modeling projections indicate reconsideration of its useJournal of Gastroenterology and Hepatology, 2010
- Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysisBMC Cancer, 2008
- Phase I Study of Individualized Stereotactic Body Radiotherapy for Hepatocellular Carcinoma and Intrahepatic CholangiocarcinomaJournal of Clinical Oncology, 2008
- Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic FactorsAnnals of Surgical Oncology, 2007
- Fractionated Stereotactic Radiotherapy in Patients with Primary Hepatocellular CarcinomaJapanese Journal of Clinical Oncology, 2006
- Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii studyActa Oncologica, 2006
- Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomyBritish Journal of Surgery, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002